UCB Pharma S.A. et al v. Nektar Therapeutics
| UCB Pharma S.A. and Celltech R&D Limited |
| Nektar Therapeutics |
| 1:2020cv00650 |
| May 15, 2020 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent |
| 28 U.S.C. ยง 1338 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 3, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 STIPULATION TO EXTEND TIME re: Defendant's Answer to Complaint to through and including July 27, 2020 - filed by Nektar Therapeutics. (Farnan, Kelly) |
SO ORDERED, re #10 STIPULATION TO EXTEND TIME re: Defendant's Answer to Complaint to through and including July 27, 2020 filed by Nektar Therapeutics. Set/Reset Answer Deadlines: Nektar Therapeutics answer due 7/27/2020. Signed by Judge Colm F. Connolly on 6/24/2020. (fms)
|
| Filing 9 SUMMONS Returned Executed by UCB Pharma S.A., Celltech R&D Limited. Nektar Therapeutics served on 6/5/2020, answer due 6/26/2020. (Raucci, Anthony) |
| Filing 8 REDACTED VERSION of #2 Complaint, by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: #1 Exhibits A-H)(Raucci, Anthony) |
|
SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney James Trainor, Robert Counihan, Eric Majchrzak, Kathryn Easterling, and Eric Menist filed by UCB Pharma S.A., Celltech R&D Limited. Signed by Judge Colm F. Connolly on 5/21/2020. (fms)
|
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney James Trainor, Robert Counihan, Eric Majchrzak, Kathryn Easterling, and Eric Menist - filed by Celltech R&D Limited, UCB Pharma S.A.. (Raucci, Anthony) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (myr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent UCB S.A. and Celltech Group Limited for Celltech R&D Limited, and identifying Corporate Parent UCB S.A. for UCB Pharma S.A. filed by Celltech R&D Limited, UCB Pharma S.A.(myr). |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,767,784 B2 ;8,193,306 B2 ;8,461,295 B2 ;8,809,489 B2. (myr) |
| Filing 3 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Filing 2 [SEALED] COMPLAINT filed against Nektar Therapeutics - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-2933225.) - filed by UCB Pharma S.A., Celltech R&D Limited. (Attachments: #1 Exhibit A-H, #2 Civil Cover Sheet)(myr) |
| Filing 1 PLAINTIFFS' MOTION FOR LEAVE TO FILE COMPLAINT UNDER SEAL - filed by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: #1 Text of Proposed Order)(myr) |
|
SO ORDERED, re #1 MOTION to Seal Complaint and Exhibits: filed by UCB Pharma S.A., Celltech R&D Limited. Signed by Judge Colm F. Connolly on 5/15/20. (rwc)
|
| Remark: Exit electronic copies to Duty Judge (CFC). (myr) |
| Remark : Case submitted for routine judicial assignment. (rwc) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
